Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02092571 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women
A Phase 1 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT02092571 is a Phase 1 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 56 participants.
The verdict
NCT02092571, a Phase 1 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
A study to assess the pharmacokinetics of 2 progesterone vaginal rings in postmenopausal women
Interventions
- DRUG Progesterone vaginal ring,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02092571
The ClinicalTrials.gov registry entry for NCT02092571 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Progesterone vaginal ring, is the first listed.
NCT02092571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02092571 about?
NCT02092571 is a clinical study titled "A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women". A study to assess the pharmacokinetics of 2 progesterone vaginal rings in postmenopausal women
What is the current status of trial NCT02092571?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2014-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02092571?
The interventions under investigation include: Progesterone vaginal ring, (DRUG).
Who is sponsoring clinical trial NCT02092571?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.